Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 3

1.

Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors.

Kulke MH, Bergsland EK, Ryan DP, Enzinger PC, Lynch TJ, Zhu AX, Meyerhardt JA, Heymach JV, Fogler WE, Sidor C, Michelini A, Kinsella K, Venook AP, Fuchs CS.

J Clin Oncol. 2006 Aug 1;24(22):3555-61.

PMID:
16877721
2.

Optimizing drug delivery for enhancing therapeutic efficacy of recombinant human endostatin in cancer treatment.

Xu F, Ma Q, Sha H.

Crit Rev Ther Drug Carrier Syst. 2007;24(5):445-92. Review.

PMID:
18197781
3.

Unraveling the mysteries of endostatin.

Fu Y, Tang H, Huang Y, Song N, Luo Y.

IUBMB Life. 2009 Jun;61(6):613-26. doi: 10.1002/iub.215. Review.

Supplemental Content

Support Center